{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T02:06:25Z","timestamp":1779242785971,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["P2GEP3_178155"],"award-info":[{"award-number":["P2GEP3_178155"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016056","name":"Minderoo Foundation","doi-asserted-by":"publisher","award":["COV-001"],"award-info":[{"award-number":["COV-001"]}],"id":[{"id":"10.13039\/501100016056","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV017302"],"award-info":[{"award-number":["INV017302"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014607","name":"Royal Children's Hospital Foundation","doi-asserted-by":"publisher","award":["2020-1263 BRACE Trial"],"award-info":[{"award-number":["2020-1263 BRACE Trial"]}],"id":[{"id":"10.13039\/100014607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1197117"],"award-info":[{"award-number":["GNT1197117"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Accurately identifying COVID-19 episodes was crucial during the pandemic for evaluating interventions. Results from diagnostic tools like PCR, rapid antigen test (RAT) and serology are affected by factors such as timing of tests and vaccination status. The BRACE trial developed an algorithm integrating these diagnostic tools for illness episode classification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In the BRACE trial, 3988 participants reported 5512 febrile\/respiratory illness episodes and provided longitudinal blood samples over one year. SARS-CoV-2 diagnosis relied on a three-component algorithm: (1) a serology algorithm assessing anti-SARS-CoV-2 nucleocapsid antibody seroconversion, (2) a PCR\/RAT algorithm, and (3) an episode interpretation algorithm combining serology and PCR\/RAT results to categorise episodes as COVID-19, Not COVID-19 or Uncertain. The algorithms accounted for vaccination status and timing of testing relative to symptom onset to refine episode classifications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 5512 illness episodes, 890 (16%) were classified as COVID-19, 3852 (70%) as Not COVID-19, and 770 (14%) as Uncertain. Compared to relying solely on PCR\/RAT results, integrating serology in the algorithm reduced the proportion of Uncertain classifications by more than half. Among the COVID-19 episodes, 89% were identified by positive PCR\/RAT results, and the remaining 11% (with missing or negative PCR\/RAT tests) were identified by serology. Discordance between PCR\/RAT and serology occurred in 9% of episodes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>An algorithm integrating PCR\/RAT and serology results in the context of test timing and vaccine status enabled the accurate identification of COVID-19 episodes and minimised the number of episodes that would otherwise have been classified as Uncertain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>The BRACE trial: BCG vaccination to reduce the impact of COVID-19 in healthcare workers. ClinicalTrials.gov NCT04327206, Registration date:27 March 2020.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-026-13128-6","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T09:49:41Z","timestamp":1775555381000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Optimising COVID-19 episode identification using serology and PCR\/rapid antigen testing: insights from the BRACE trial"],"prefix":"10.1186","volume":"26","author":[{"given":"Ellie","family":"McDonald","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laure F.","family":"Pittet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Bonten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio","family":"Croda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margareth","family":"Dalcolmo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. J.","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glauce","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaya","family":"Gardiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Gwee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Jardim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"Lacerda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaela","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Lynn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurens","family":"Manning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten P.","family":"Perrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Prat-Aymerich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco Antonio Moreira","family":"Puga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Richmond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Rodr\u00edguez-Ba\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ushma","family":"Wadia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adilia","family":"Warris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigel","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8404-4462","authenticated-orcid":false,"given":"Nicole L.","family":"Messina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the BRACE Trial Consortium Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"issue":"10","key":"13128_CR1","doi-asserted-by":"publisher","first-page":"e052101","DOI":"10.1136\/bmjopen-2021-052101","volume":"11","author":"LF Pittet","year":"2021","unstructured":"Pittet LF, Messina NL, Gardiner K, Orsini F, Abruzzo V, Bannister S, et al. BCG vaccination to reduce the impact of COVID-19 in healthcare workers: Protocol for a randomised controlled trial (BRACE trial). BMJ Open. 2021;11(10):e052101.","journal-title":"BMJ Open"},{"issue":"17","key":"13128_CR2","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1056\/NEJMoa2212616","volume":"388","author":"LF Pittet","year":"2023","unstructured":"Pittet LF, Messina NL, Orsini F, Moore CL, Abruzzo V, Barry S, et al. Randomized Trial of BCG Vaccine to Protect against Covid-19 in Health Care Workers. N Engl J Med. 2023;388(17):1582\u201396.","journal-title":"N Engl J Med"},{"key":"13128_CR3","unstructured":"Pittet LF, Messina NL, McDonald E, Orsini F, Barry S, Bonten M, et al. Bacille Calmette-Gu\u00e9rin vaccination to prevent febrile and respiratory illness in adults (BRACE): secondary outcomes of a randomised controlled phase 3 trial. eClinicalMedicine. 2024;72."},{"issue":"5","key":"13128_CR4","doi-asserted-by":"publisher","first-page":"106267","DOI":"10.1016\/j.jinf.2024.106267","volume":"89","author":"E McDonald","year":"2024","unstructured":"McDonald E, Pittet LF, Barry SE, Bonten M, Campbell J, Croda J, et al. Antecedent and persistent symptoms in COVID-19 and other respiratory illnesses: Insights from prospectively collected data in the BRACE trial. J Infect. 2024;89(5):106267.","journal-title":"J Infect"},{"issue":"6","key":"13128_CR5","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.pathol.2021.05.093","volume":"53","author":"KA Bond","year":"2021","unstructured":"Bond KA, Williams E, Nicholson S, Lim S, Johnson D, Cox B, et al. Longitudinal evaluation of laboratory-based serological assays for SARS-CoV-2 antibody detection. Pathology. 2021;53(6):773\u20139.","journal-title":"Pathology"},{"issue":"4","key":"13128_CR6","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","volume":"5","author":"M Letko","year":"2020","unstructured":"Letko M, Marzi A, Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol. 2020;5(4):562\u20139.","journal-title":"Nat Microbiol"},{"key":"13128_CR7","unstructured":"Elecsys\u00ae Anti-SARS-CoV-2. Immunoassay for the qualitative detection of antibodies against SARS-CoV-2. In: Ltd RDI, editor. 2020."},{"key":"13128_CR8","doi-asserted-by":"crossref","unstructured":"Noble C, McDonald E, Nicholson S, Biering-Sorensen S, Pittet LF, Byrne AL, et al. Characterising the SARS-CoV-2 nucleocapsid (N) protein antibody response. J Infect. 2025:106436.","DOI":"10.1016\/j.jinf.2025.106436"},{"key":"13128_CR9","doi-asserted-by":"publisher","first-page":"104500","DOI":"10.1016\/j.jcv.2020.104500","volume":"129","author":"GC Mak","year":"2020","unstructured":"Mak GC, Cheng PK, Lau SS, Wong KK, Lau CS, Lam ET, et al. Evaluation of rapid antigen test for detection of SARS-CoV-2 virus. J Clin Virol. 2020;129:104500.","journal-title":"J Clin Virol"},{"key":"13128_CR10","doi-asserted-by":"crossref","unstructured":"Czajka H, Zapolnik P, Krzych L, Kmiecik W, Stopyra L, Nowakowska A, et al. A Multi-Center, randomised, double-blind, placebo-controlled phase III clinical trial evaluating the impact of BCG Re-vaccination on the incidence and severity of sars-cov-2 infections among symptomatic healthcare professionals during the COVID-19 pandemic in Poland-First Results. Vaccines (Basel). 2022;10(2).","DOI":"10.3390\/vaccines10020314"},{"key":"13128_CR11","doi-asserted-by":"publisher","first-page":"101414","DOI":"10.1016\/j.eclinm.2022.101414","volume":"48","author":"CM Upton","year":"2022","unstructured":"Upton CM, van Wijk RC, Mockeliunas L, Simonsson USH, van den McHarry K, et al. Safety and efficacy of BCG re-vaccination in relation to COVID-19 morbidity in healthcare workers: A double-blind, randomised, controlled, phase 3 trial. EClinicalMedicine. 2022;48:101414.","journal-title":"EClinicalMedicine"},{"issue":"6","key":"13128_CR12","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.cmi.2023.01.019","volume":"29","author":"EL Koekenbier","year":"2023","unstructured":"Koekenbier EL, van de Fohse K, Oosterheert JJ, van Nieuwkoop C, Hoogerwerf JJ, et al. Bacillus Calmette-Guerin vaccine for prevention of COVID-19 and other respiratory tract infections in older adults with comorbidities: a randomized controlled trial. Clin Microbiol Infect. 2023;29(6):781\u20138.","journal-title":"Clin Microbiol Infect"},{"key":"13128_CR13","doi-asserted-by":"publisher","first-page":"841868","DOI":"10.3389\/fimmu.2022.841868","volume":"13","author":"LRB Dos Anjos","year":"2022","unstructured":"Dos Anjos LRB, da Costa AC, Cardoso A, Guimaraes RA, Rodrigues RL, Ribeiro KM, et al. Efficacy and Safety of BCG Revaccination With M. bovis BCG Moscow to Prevent COVID-19 Infection in Health Care Workers: A Randomized Phase II Clinical Trial. Front Immunol. 2022;13:841868.","journal-title":"Front Immunol"},{"issue":"9","key":"13128_CR14","doi-asserted-by":"publisher","first-page":"100728","DOI":"10.1016\/j.xcrm.2022.100728","volume":"3","author":"DL Faustman","year":"2022","unstructured":"Faustman DL, Lee A, Hostetter ER, Aristarkhova A, Ng NC, Shpilsky GF, et al. Multiple BCG vaccinations for the prevention of COVID-19 and other infectious diseases in type 1 diabetes. Cell Rep Med. 2022;3(9):100728.","journal-title":"Cell Rep Med"},{"key":"13128_CR15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ijid.2023.02.014","volume":"130","author":"AP Santos","year":"2023","unstructured":"Santos AP, Werneck GL, Dalvi APR, Dos Santos CC, Tierno P, Condelo HS, et al. The effect of BCG vaccination on infection and antibody levels against SARS-CoV-2-The results of ProBCG: a multicenter randomized clinical trial in Brazil. Int J Infect Dis. 2023;130:8\u201316.","journal-title":"Int J Infect Dis"},{"issue":"8","key":"13128_CR16","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1093\/infdis\/jiaa467","volume":"222","author":"K Bond","year":"2020","unstructured":"Bond K, Nicholson S, Lim SM, Karapanagiotidis T, Williams E, Johnson D, et al. Evaluation of Serological Tests for SARS-CoV-2: Implications for Serology Testing in a Low-Prevalence Setting. J Infect Dis. 2020;222(8):1280\u20138.","journal-title":"J Infect Dis"},{"issue":"3","key":"13128_CR17","doi-asserted-by":"publisher","first-page":"470","DOI":"10.5811\/westjem.2020.4.47370","volume":"21","author":"T Zitek","year":"2020","unstructured":"Zitek T. The Appropriate Use of Testing for COVID-19. West J Emerg Med. 2020;21(3):470\u20132.","journal-title":"West J Emerg Med"},{"issue":"12","key":"13128_CR18","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1038\/s41564-020-00813-8","volume":"5","author":"J Seow","year":"2020","unstructured":"Seow J, Graham C, Merrick B, Acors S, Pickering S, Steel KJA, et al. Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans. Nat Microbiol. 2020;5(12):1598\u2013607.","journal-title":"Nat Microbiol"},{"issue":"1","key":"13128_CR19","doi-asserted-by":"publisher","first-page":"3436","DOI":"10.1038\/s41467-020-17317-y","volume":"11","author":"CH GeurtsvanKessel","year":"2020","unstructured":"GeurtsvanKessel CH, Okba NMA, Igloi Z, Bogers S, Embregts CWE, Laksono BM, et al. An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment. Nat Commun. 2020;11(1):3436.","journal-title":"Nat Commun"},{"issue":"1","key":"13128_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ajic.2020.07.011","volume":"49","author":"B Boger","year":"2021","unstructured":"Boger B, Fachi MM, Vilhena RO, Cobre AF, Tonin FS, Pontarolo R. Systematic review with meta-analysis of the accuracy of diagnostic tests for COVID-19. Am J Infect Control. 2021;49(1):21\u20139.","journal-title":"Am J Infect Control"},{"key":"13128_CR21","doi-asserted-by":"crossref","unstructured":"Khalid MF, Selvam K, Jeffry AJN, Salmi MF, Najib MA, Norhayati MN, Aziah I. Performance of rapid antigen tests for COVID-19 diagnosis: a systematic review and meta-analysis. Diagnostics (Basel). 2022;12(1).","DOI":"10.3390\/diagnostics12010110"},{"issue":"2","key":"13128_CR22","doi-asserted-by":"publisher","first-page":"e13706","DOI":"10.1111\/eci.13706","volume":"52","author":"V Pecoraro","year":"2022","unstructured":"Pecoraro V, Negro A, Pirotti T, Trenti T. Estimate false-negative RT-PCR rates for SARS-CoV-2. A systematic review and meta-analysis. Eur J Clin Invest. 2022;52(2):e13706.","journal-title":"Eur J Clin Invest"},{"issue":"10","key":"13128_CR23","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1093\/infdis\/jiad316","volume":"228","author":"CCA Noble","year":"2023","unstructured":"Noble CCA, Messina NL, Pittet LF, Curtis N. Interpreting the Results of Trials of BCG Vaccination for Protection Against COVID-19. J Infect Dis. 2023;228(10):1467\u201378.","journal-title":"J Infect Dis"},{"key":"13128_CR24","doi-asserted-by":"crossref","unstructured":"Dos Santos PCP, Messina NL, de Oliveira RD, da Silva PV, Puga MAM, Dalcolmo M, et al. Effect of BCG vaccination against Mycobacterium tuberculosis infection in adult Brazilian health-care workers: a nested clinical trial. Lancet Infect Dis. 2024.","DOI":"10.1016\/S1473-3099(23)00818-6"},{"key":"13128_CR25","doi-asserted-by":"publisher","first-page":"105100","DOI":"10.1016\/j.ebiom.2024.105100","volume":"103","author":"NL Messina","year":"2024","unstructured":"Messina NL, Germano S, McElroy R, Bonnici R, Grubor-Bauk B, Lynn DJ, et al. Specific and off-target immune responses following COVID-19 vaccination with ChAdOx1-S and BNT162b2 vaccines-an exploratory sub-study of the BRACE trial. EBioMedicine. 2024;103:105100.","journal-title":"EBioMedicine"},{"key":"13128_CR26","doi-asserted-by":"publisher","first-page":"1172851","DOI":"10.3389\/fimmu.2023.1172851","volume":"14","author":"NL Messina","year":"2023","unstructured":"Messina NL, Sperotto MG, Puga MAM, da Silva PV, de Oliveira RD, Moore CL, et al. Impact of vaccine platform and BCG vaccination on antibody responses to COVID-19 vaccination. Front Immunol. 2023;14:1172851.","journal-title":"Front Immunol"},{"issue":"4","key":"13128_CR27","doi-asserted-by":"publisher","first-page":"e1387","DOI":"10.1002\/cti2.1387","volume":"11","author":"NL Messina","year":"2022","unstructured":"Messina NL, Germano S, McElroy R, Rudraraju R, Bonnici R, Pittet LF, et al. Off-target effects of bacillus Calmette-Guerin vaccination on immune responses to SARS-CoV-2: implications for protection against severe COVID-19. Clin Transl Immunol. 2022;11(4):e1387.","journal-title":"Clin Transl Immunol"},{"key":"13128_CR28","doi-asserted-by":"crossref","unstructured":"Stevens NE, Ryan FJ, Messina NL, Blake SJ, Norton TS, Germano S, et al. No evidence of durable trained immunity after two doses of adenovirus-vectored or mRNA COVID-19 vaccines. J Clin Invest. 2023;133(17).","DOI":"10.1172\/JCI171742"},{"issue":"3","key":"13128_CR29","doi-asserted-by":"publisher","first-page":"100971","DOI":"10.1016\/j.xcrm.2023.100971","volume":"4","author":"FJ Ryan","year":"2023","unstructured":"Ryan FJ, Norton TS, McCafferty C, Blake SJ, Stevens NE, James J, et al. A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA and adenovirus vectored vaccines. Cell Rep Med. 2023;4(3):100971.","journal-title":"Cell Rep Med"},{"issue":"1","key":"13128_CR30","doi-asserted-by":"publisher","first-page":"e20240042","DOI":"10.1002\/smo.20240042","volume":"3","author":"L Zhang","year":"2025","unstructured":"Zhang L, Zhou J, Shimoni O, Wen S, Alghalayini A, Liu Y, et al. A COVID-19 rapid antigen test employing upconversion nanoparticles. Smart Mol. 2025;3(1):e20240042.","journal-title":"Smart Mol"},{"key":"13128_CR31","doi-asserted-by":"crossref","unstructured":"Wang W, Wang J, Hu Z, Yan X, Gao Q, Li X, et al. Advancing Aggregation-induced emission\u2010derived biomaterials in viral, tuberculosis, and fungal infectious diseases. Aggregate. 2024;6(3).","DOI":"10.1002\/agt2.715"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13128-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13128-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13128-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T01:45:21Z","timestamp":1779241521000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13128-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13128"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13128-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"28 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Royal Children\u2019s Hospital Melbourne Human Research Ethics Committee (Reference Number: 62586) in accordance with the Declaration of Helsinki. The protocol was approved by the ethics committee at each site and all participants provided informed consent. The trial was overseen by a steering committee and a data safety and monitoring board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"PCR has received investigator-initiated research grants to his institution from Sanofi outside this work and has received institutional funding from GlaxoSmithKline and Sanofi for local and international lectures and from AstraZeneca, Clover Biopharmaceuticals, GlaxoSmithKline, Novavax, Sanofi, and Pfizer for participation in vaccine scientific advisory boards unrelated to this work. He has been an investigator in sponsored, multicentre vaccine trials for AstraZeneca, Moderna, Novavax, Pfizer, and Sanofi with funding to his institution. He is Chief investigator on an investigator led COVID-19 vaccine trial and institution has received funding from the Medical Research Future Fund. HSM has received investigator-initiated research grants to her institution from Sanofi and Pfizer outside this work. She has been an investigator in sponsored, multicentre vaccine trials for Iliad, Seqirus and Pfizer, with funding to her institution. She is a Chief investigator on an investigator led COVID-19 vaccine trial and institution has received funding from the Medical Research Future Fund. All other authors declare that they have no known competing financial interests or personal relationships that could appear to have influenced the work reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"974"}}